Orphalan SA

Orphalan is a privately owned international pharmaceutical company founded in 2011. Its mission is to develop and deliver innovative therapies for people living with rare and debilitating diseases. The company specializes in the development and commercialization of orphan drugs, including a trientine tetrahydrochloride product, and works internationally to improve access to specialized medicines for underserved communities through partnerships and patient-focused initiatives.